Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The present study will provide information on whether the somatostatin analog, octreotide acetate, could have an inhibitory effect on circulating chromogranin A. The demonstration of an antisecretory effect of somatostatin analogs could offer a rationale for a large scale randomized study.
Epistemonikos ID: f93db5251bd3b69f37ab8456b6118cded301e9b5
First added on: May 04, 2024